Monitor Protein Therapeutic Color Changes With LC-MS
Fill out the form below and we'll send your colleague an invitation to the "Monitor Protein Therapeutic Color Changes With LC-MS" event.
The color of a therapeutic monoclonal antibody solution is a critical quality attribute (CQA), essential for maintaining consistency throughout clinical trials and commercial production.
Color changes are often associated with advanced glycation end products (AGEs), which form as post-translational modifications (PTMs). Monitoring these changes is essential, as they can impact both the efficacy and safety of the final drug product.
This webinar explores the implementation of a liquid chromatography-mass spectrometry (LC-MS) workflow for peptide mapping to investigate and track these PTMs.
Watch this webinar to explore:
- Key product quality attributes associated with color changes in therapeutics
- The connection between AGEs and color variation
- The use of LC-MS to quantitatively monitor AGEs in drug development